Convidados


Clique no nome do convidado e confira o minicurrículo:


Convidados Internacionais

DAVID ISENBERG 
DAVID ISENBERG
I trained at St Bartholomew’s Hospital, several North and Central London teaching hospitals and the New England Medical Center in Boston. I have been academic director of Rheumatology at University College London since 1996. I am an ex-president of the British Society for Rheumatology (2004-2006) and ex-Chair of the BSR’s Biologics Register Committee (2006-2011). Currently I chair Lupus UK’s Research Committee. I am a non-executive director of the Royal National Orthopaedic Hospital (Stanmore) and the major UK arthritis charity Versus Arthritis. I won the Hess prize (2010) awarded by the Lupus Foundation of America for outstanding contribution to SLE Research – the first non- North American to win it. I won the Roger Demers Award in 2012 from the Laurentian Conference of Rheumatology for “unique contribution to international rheumatology” and the Reumeritas Award given biannually by the Portuguese Rheumatology Society for scientific merit in the field of rheumatology (2016). I have published 560 original articles and over 280 reviews, chapters and written and/or edited 20 books. My alter-ego ‘Lupus Dave’ sings and writes for ‘Lupus Dave and The Davettes’!

DAVID RUBIN 
DAVID RUBIN
Dr. David T. Rubin is the Joseph B. Kirsner Professor of Medicine, Chief of the Section of Gastroenterology, Hepatology & Nutrition and the Co-Director of the Digestive Diseases Center at The University of Chicago Medicine. Dr. Rubin earned a medical degree with honors at The University of Chicago Pritzker School of Medicine. He completed his residency in internal medicine and fellowships in gastroenterology and clinical medical ethics at the University of Chicago, where he served as Chief Resident and Chief Fellow. Prior to his current appointments, Dr. Rubin served for 11 years as Director of the Gastroenterology, Hepatology and Nutrition fellowship program. He also currently serves as an associate faculty member at the MacLean Center for Clinical Medical Ethics and an associate investigator at the University of Chicago Comprehensive Cancer Center.
Dr. Rubin is a Fellow of the American Gastroenterological Association (AGA), the American College of Gastroenterology (ACG), the American Society for Gastrointestinal Endoscopy (ASGE) and the American College of Physicians (ACP) and an active national member of the Crohn’s & Colitis Foundation, and is on the Board of Trustees for the ACG. Among numerous awards and honors, Dr. Rubin was chosen by his peers as a member of Best Doctors (recognized for superior clinical ability) and America’s Top Physicians (gastroenterology). Additionally, he twice received the ACG’s Governor’s Award of Excellence in Clinical Research (2003 and 2013), the Cancer Research Foundation Young Investigator’s Award (2004), and the UC Postgraduate Teaching Award in recognition of significant contributions for fellowship education (2006). In 2012, he received the CCF Rosenthal Award, a national leadership award bestowed upon a volunteer who has contributed in an indisputable way to the quality of life of patients and families. He is currently the Chair-elect of the National Scientific Advisory Committee of the Crohn’s and Colitis Foundation. He is an Associate Editor of the journal Gastroenterology and Editor of the ACG On-Line Educational Universe.
Dr. Rubin is the editor of a best-selling book on inflammatory bowel disease (IBD), now in its 3rd edition, an associate editor of the 11th edition of Sleisenger and Fordtran’s Gastrointestinal and Liver Disease, and an author or coauthor of many peer-reviewed articles on treatment and management of IBD, cancer in IBD and novel paradigms, as well as the first author of the in progress ACG Guidelines for ulcerative colitis. His current research is in the area of progressive complications from uncontrolled inflammation, the doctor-patient relationship in IBD, and a variety of collaborative studies related to the microbiome and intestinal disease. He is also a featured media contact for issues related to IBD, appearing on satellite radio, television, print media and maintains a popular twitter feed @IBDMD (>8000 followers). His principal research interests include novel IBD therapies and outcomes, colon cancer prevention, and clinical medical ethics.

OLIVER DISTLER 
OLIVER DISTLER
Oliver Distler is Professor at the University of Zurich and Chairman of the Department of Rheumatology, University Hospital Zurich and the Balgrist University Hospital in Zurich, Switzerland. Since 2018, he is Head of the Business Division, Traumatology-Dermatology-Rheumatology-Plastic Surgery and Emergency Medicine (TDR), at the University Hospital Zurich in Switzerland and Board Member at the Faculty of Medicine at the University of Zurich. Next to his clinical work at the outpatient and inpatient clinic in the field of Rheumatology, he is regularly involved in teaching activities and speaker at international conferences and further educations. He is also involved in the organization of international major scientific meetings and national further education. In addition, he is Co-Founder of multiple international networks and training programs, e.g. EUSTAR (European Scleroderma Trials and Research Group), World Scleroderma Congress, JSRD (Journal of scleroderma and related diseases), Educational Masterclass series on SSc-ILD. With over 250 original research publications, he is also heading the Center of Experimental Rheumatology of the University of Zurich and supervisor of various graduate students and postdoctoral fellows. He is ad hoc reviewer for all major Rheumatology journals (including the leading journals ARD, A&R, Lancet Rheumatology), for journals from General Internal Medicine and other fields (including NEJM and Lancet), different national and international funding agencies (including e.g. DFG), different foundations (including Pfizer Foundation, Hartmann Müller Foundation) and frequent abstract reviewer for the large international congresses in Rheumatology (including EULAR, ACR, Scleroderma World Congress). He is also editorial board member of Lancet Rheumatology and Annals of the Rheumatic Diseases (ARD).

local do evento


Realização



Agência Oficial de Turismo



Patrocinador Ouro


Patrocinador Prata


Patrocínio